PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 254 filers reported holding PHARMACYCLICS INC in Q3 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $4,005,000 | -18.5% | 15,646 | -61.1% | 0.14% | -13.9% |
| Q4 2014 | $4,915,000 | +52.6% | 40,200 | +46.6% | 0.17% | +71.1% |
| Q3 2014 | $3,221,000 | -42.8% | 27,428 | -56.3% | 0.10% | -35.8% |
| Q2 2014 | $5,627,000 | -23.0% | 62,728 | -14.0% | 0.15% | -23.7% |
| Q1 2014 | $7,306,000 | +118.7% | 72,902 | +130.9% | 0.20% | +100.0% |
| Q4 2013 | $3,340,000 | +10.6% | 31,575 | -16.9% | 0.10% | -2.0% |
| Q2 2013 | $3,020,000 | – | 38,005 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
| DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
| HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
| Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
| Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
| BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
| Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
| HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
| Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
| BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |